Damora Therapeutics, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Schambye Hans T. | Chief Executive Officer | Option Exercise | 1,360 | — | — | 4,757 | Jul 3, 2025 |
| Winslow Garrett | General Counsel | Sale | 260 | $3.39 | $881 | 1,429 | Jul 3, 2025 |
| Firmani Lori | Interim CFO | Sale | 147 | $3.39 | $498 | 692 | Jul 3, 2025 |
| Winslow Garrett | General Counsel | Sale | 471 | $5.60 | $2,638 | 1,009 | Jan 3, 2025 |
| Firmani Lori | Interim CFO | Sale | 261 | $5.63 | $1,469 | 465 | Jan 3, 2025 |
| Schambye Hans T. | Chief Executive Officer | Sale | 1,341 | $5.60 | $7,510 | 3,397 | Jan 3, 2025 |
| OrbiMed Advisors Israel II Ltd | — | Sale | 248,819 | $0.75 | $186,614 | 631,048 | Aug 15, 2023 |
| OrbiMed Capital GP VII LLC | — | Sale | 153,078 | $3.00 | $459,234 | 2,105,909 | Jul 31, 2023 |
| OrbiMed Capital GP VII LLC | — | Sale | 4,700 | $2.92 | $13,724 | 909,567 | Jul 25, 2023 |
| OrbiMed Advisors Israel II Ltd | — | Sale | 52,800 | $2.40 | $126,720 | 914,267 | Jul 13, 2023 |
| ORBIMED ADVISORS LLC | — | Sale | 660 | $1.97 | $1,300 | 179,753 | Apr 13, 2023 |
| OrbiMed Advisors Israel II Ltd | — | Sale | 641 | $1.81 | $1,160 | 985,647 | Apr 12, 2023 |
| OrbiMed Genesis GP LLC | — | Sale | 487 | $2.00 | $974 | 186,613 | Apr 5, 2023 |
| Lindmark Bertil | Chief Medical Officer | Purchase | 14,604 | $2.16 | $31,545 | 16,604 | Mar 22, 2022 |
| Schambye Hans T. | Chief Executive Officer | Purchase | 5,000 | $2.15 | $10,750 | 52,428 | Mar 22, 2022 |
| Winslow Garrett | General Counsel | Purchase | 2,000 | $2.48 | $4,960 | 4,000 | Dec 3, 2021 |
| Freve Jonathan | Chief Financial Officer | Purchase | 4,000 | $2.49 | $9,960 | 12,000 | Dec 3, 2021 |
| Schambye Hans T. | Chief Executive Officer | Purchase | 4,500 | $3.50 | $15,750 | 47,428 | Nov 9, 2021 |
| Freve Jonathan | Chief Financial Officer | Purchase | 3,000 | $3.40 | $10,200 | 8,000 | Nov 8, 2021 |
| Freve Jonathan | Chief Financial Officer | Purchase | 3,000 | $3.92 | $11,760 | 5,000 | Aug 18, 2021 |
| Lindmark Bertil | Chief Medical Officer | Purchase | 2,000 | $5.26 | $10,520 | 2,000 | Jun 28, 2021 |
| Schambye Hans T. | Chief Executive Officer | Purchase | 3,000 | $5.11 | $15,330 | 42,928 | Jun 24, 2021 |
| Freve Jonathan | Chief Financial Officer | Purchase | 2,000 | $4.74 | $9,480 | 2,000 | Jun 23, 2021 |
| Winslow Garrett | General Counsel | Purchase | 2,000 | $4.80 | $9,600 | 2,000 | Jun 23, 2021 |
| Novo Holdings A/S | — | Purchase | 333,333 | $15.00 | $4,999,995 | 2,497,791 | Nov 2, 2020 |
| Christgau Stephan | — | Purchase | 66,666 | $15.00 | $999,990 | 546,136 | Nov 2, 2020 |
| Khuong Chau Quang | — | C | 822,311 | — | — | 822,311 | Nov 2, 2020 |
| Schambye Hans T. | Chief Executive Officer | C | 13,931 | — | — | 39,928 | Nov 2, 2020 |
| Munshi Amit | — | C | 4,793 | — | — | 4,793 | Nov 2, 2020 |
| OrbiMed Israel GP II, L.P. | — | C | 2,055,824 | — | — | 2,055,824 | Nov 2, 2020 |
| Pedersen Anders | Chief Operating Officer | C | 3,746 | — | — | 3,746 | Nov 2, 2020 |
| GOLDFISCHER CARL | — | C | 9,587 | — | — | 9,587 | Nov 2, 2020 |